Phm bolsa
Looking for more advanced features?
Add to a list Add to a list. To use this feature you must be a member. Pharma Mar, S. Real-time Estimate Tradegate Other stock markets. Funds and ETFs. Chart Pharma Mar, S.
Phm bolsa
PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines. The Company is inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. PharmaMar intends to continue to be the world leader in marine medicinal discovery, development and innovation. PharmaMar has other clinical-stage programs under development for several types of solid cancers: lurbinectedin, ecubectedin, PM and PM It also has a preclinical and clinical program in virology. PharmaMar also wholly owns Sylentis, a company dedicated to researching therapeutic applications of gene silencing RNAi. To obtain detailed information or information in other formats, please contact BME Market Data at marketdata grupobme. The information provided by the different websites of Grupo BME is for internal use only. Please contact us at marketdata grupobme. Profile PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines.
Jose Maria Jimeno td:not. Learn more 1. The information provided by the different websites of Grupo BME is phm bolsa internal use only.
.
Pharma Mar, S. About the company. The company operates through Oncology and RNA interference segments. Earnings are forecast to grow High level of non-cash earnings. Profit margins 0. New major risk - Dividend sustainability Mar Price target decreased by 9. See more updates Recent updates. New major risk - Earnings quality Jul
Phm bolsa
Add to a list Add to a list. To use this feature you must be a member. Pharma Mar, S.
Nh 66 shortcut
Profile PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines. Latest news about Pharma Mar, S. PharmaMar intends to continue to be the world leader in marine medicinal discovery, development and innovation. News in other languages on Pharma Mar, S. Looking for more advanced features? Place, manage and monitor your orders directly from charts for simple and intuitive control. Quarterly earnings - Rate of surprise. Add to a list Add to a list. Montserrat Andrade Detrell td:not. Display up to 20 simultaneous charts across one or several monitors. Several years of intraday historical data. PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines.
.
An interface designed for speed, bringing together all useful information. The Company is active globally. PharmaMar has other clinical-stage programs under development for several types of solid cancers: lurbinectedin, ecubectedin, PM and PM Practice trading on past data, on any instrument, in any time frame. Several years of intraday historical data. The information provided by the different websites of Grupo BME is for internal use only. Trend, support and resistance lines can be drawn automatically on any of your charts. Find theoretical price and greeks based on the current market values, and display projected combined performance for multiple positions. Multi-criteria alerts Set alerts based on one or multiple conditions, in one or multiple time frames. Montserrat Andrade Detrell td:not.
Infinitely to discuss it is impossible
I thank for the help in this question, now I will know.